Cargando…

Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high‐fat diet

Nonalcoholic steatohepatitis (NASH) is a common cause of liver cirrhosis and hepatocellular carcinoma (HCC). However, effective therapeutic strategies for preventing and treating NASH‐mediated liver cirrhosis and HCC are lacking. Cholesterol is closely associated with vascular endothelial growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miura, Kouichi, Ohnishi, Hirohide, Morimoto, Naoki, Minami, Shinichiro, Ishioka, Mitsuaki, Watanabe, Shunji, Tsukui, Mamiko, Takaoka, Yoshinari, Nomoto, Hiroaki, Isoda, Norio, Yamamoto, Hironori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361611/ https://www.ncbi.nlm.nih.gov/pubmed/30520543 http://dx.doi.org/10.1111/cas.13902

Ejemplares similares

A 79-year-old Woman with Acute Hepatitis B Caused by the Infection of Subgenotype D1 Hepatitis B Virus in Japan: A Case Study
por: Hashimoto, Kosei, et al.
Publicado: (2018)

Acute Liver Failure Caused by the Transmission of Hepatitis B Virus from the Spouse after 38 Years of Marriage
por: Sato, Naoto, et al.
Publicado: (2019)

Usefulness of Gd-EOB-DTPA-enhanced MRI for evaluating the potential for early development of hepatocellular carcinoma after HCV eradication by direct-acting antiviral treatment
por: Morimoto, Naoki, et al.
Publicado: (2019)

Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities
por: Miura, Kouichi, et al.
Publicado: (2022)

Conventional Therapies Do Not Prolong the Prognosis of Hepatocellular Carcinoma Patients with Extrahepatic Metastases under Receiving of Tyrosine Kinase Inhibitors
por: Maeda, Hiroshi, et al.
Publicado: (2022)

Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study
por: Nomoto, Hiroaki, et al.
Publicado: (2020)

No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its Vicinity
por: Hirosawa, Takuya, et al.
Publicado: (2018)

Efficacy and safety of glecaprevir and pibrentasvir combination therapy in old-aged patients with chronic hepatitis C virus infection
por: Watanabe, Shunji, et al.
Publicado: (2020)

Oxidized High-Density Lipoprotein Shows a Stepwise Increase as Fibrosis Progresses in Patients with Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2021)

The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2017)

Rh-Catalyzed reductive Mannich-type reaction and its application towards the synthesis of (±)-ezetimibe
por: Isoda, Motoyuki, et al.
Publicado: (2016)

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2010)

Ezetimibe and Simvastatin Reduce Cholesterol Levels in Zebrafish Larvae Fed a High-Cholesterol Diet
por: Baek, Ji Sun, et al.
Publicado: (2012)

Asymptomatic anisakiasis of the colon incidentally diagnosed and treated during colonoscopy by retroflexion in the ascending colon
por: Tsukui, Mamiko, et al.
Publicado: (2016)

The rendezvous technique involving insertion of a guidewire in a percutaneous transhepatic gallbladder drainage tube for biliary access in a case of difficult biliary cannulation
por: Sunada, Fumiko, et al.
Publicado: (2017)

Requirement of Gα(q)/Gα(11) Signaling in the Preservation of Mouse Intestinal Epithelial Homeostasis
por: Watanabe, Noboru, et al.
Publicado: (2016)

Fungal biotransformation of ezetimibe
por: Pervaiz, Irfan, et al.
Publicado: (2014)

Ezetimibe: An Unusual Suspect in Angioedema
por: Lu, Tiffany, et al.
Publicado: (2020)

Synthesis and Modeling of Ezetimibe Analogues
por: Salgado, Mateo M., et al.
Publicado: (2021)

Ezetimibe and Cancer: Is There a Connection?
por: Gu, Jia, et al.
Publicado: (2022)

A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol
por: Niedzielski, Mateusz, et al.
Publicado: (2021)

Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia
por: Rizzo, Manfredi, et al.
Publicado: (2011)

Liver Injury Associated With Ezetimibe Monotherapy
por: Kanagalingam, Tharsan, et al.
Publicado: (2020)

Disruption of Small GTPase Rab7 Exacerbates the Severity of Acute Pancreatitis in Experimental Mouse Models
por: Takahashi, Kenichi, et al.
Publicado: (2017)

Pink-Colored Grape Berry Is the Result of Short Insertion in Intron of Color Regulatory Gene
por: Shimazaki, Mamiko, et al.
Publicado: (2011)

Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia
por: Tano, Kanako, et al.
Publicado: (2019)

Ezetimibe therapy: mechanism of action and clinical update
por: Phan, Binh An P, et al.
Publicado: (2012)

Ezetimibe: Clinical and Scientific Meaning of the IMPROVE-IT Study
por: Correia, Luis C. L.
Publicado: (2016)

Impact on urinary oxalate levels with use of ezetimibe
por: Trautman, Christopher L., et al.
Publicado: (2021)

IMPROVE-IT: A Final Closure to Carcinogenicity of Ezetimibe?
por: Lewis, Eldrin F., et al.
Publicado: (2020)

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
por: Farnier, Michel, et al.
Publicado: (2011)

Intravenous injection of neural progenitor cells facilitates angiogenesis after cerebral ischemia
por: Moriyama, Yoshiyuki, et al.
Publicado: (2013)

Is Mitogen‐Activated Protein Kinase Phosphatase 5 a Solution to the Puzzle of the Mitogen‐Activated Protein Kinase Signal in Steatohepatitis?
por: Miura, Kouichi, et al.
Publicado: (2019)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
por: Grigore, Liliana, et al.
Publicado: (2008)

The combination of Ezetimibe and Statin: a new treatment for hypercholesterolemia
por: NODARI, SAVINA, et al.
Publicado: (2007)

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
por: Hamilton-Craig, Ian, et al.
Publicado: (2010)

Niacin or Ezetimibe for Patients with, or at Risk of Coronary Heart Disease
por: Guthrie, Robert
Publicado: (2010)

The utility of ezetimibe therapy in nonalcoholic fatty liver disease
por: Jun, Baek Gyu, et al.
Publicado: (2019)

A pilot study of the effect of ezetimibe for postprandial hyperlipidemia
por: Xue, E-Zhong, et al.
Publicado: (2018)

Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and Perspectives
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ts66s854p9rgllvakr0t1mc1oo